Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Exiqon’s LNA LongRNA Gapmers

Premium

Exiqon has introduced LNA longRNA gapmers, a collection of RNase U-activating antisense oligonucleotides for the specific inhibition of mRNA and long non-coding RNAs in vitro and in vivo.

According to the company, the oligos offer high affinity and stability with low toxicity and reduced off-target effects.